(1)
Sabapathy, S.; Neslusan, C.; Yoong, K.; Teschemaker, A.; Johansen, P.; Willis, M. COST-EFFECTIVENESS OF CANAGLIFLOZIN VERSUS SITAGLIPTIN WHEN ADDED TO METFORMIN AND SULFONYLUREA IN TYPE 2 DIABETES IN CANADA. J Popl Ther Clin Pharmacol 2018, 23 (2).